The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...
The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...
The study revealed the small-molecule signaling system for mammalian cell-cell communication that combines super-sensitivity with a chassis-friendly, low-burden design, and demonstrated the system's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback